Prenatal Diagnosis of Antenatal Midgut Volvulus: Specific Ultrasound Features

December 4, 2017 updated by: University Hospital, Montpellier

Objective:

The small bowel volvulus is a rare cause of intestinal obstruction which may occur in utero and whose prenatal diagnosis is difficult.Sonographic signs are mainly indirect and non specific.The aim of this study is to present a retrospective analysis of prenatal sonographicfindings in fetal segmental midgut volvulus.Thanks to this series the investigators could highlight the more specifics signs of the volvulus included a new pattern.

Study Overview

Detailed Description

Objective:

The small bowel volvulus is a rare cause of intestinal obstruction which may occur in utero and whose prenatal diagnosis is difficult. Sonographic signs are mainly indirect and nonspecific. The aim of this study is to present a retrospective analysis of prenatal sonographic findings in fetal segmental midgut volvulus. Thanks to this series the investigators could highlight the more specifics signs of the volvulus included a new pattern.

Methods:

Unicentric retrospective analysis of cases of prenatal midgut volvulus between 2006 and 2017. The primary inclusion criteria was postnatal diagnosis of prenatal volvulus based on post-natal findings and prenatal imaging findings. The exclusion criteria was the absence of prenatal imaging assessment. The investigators collected the clinical history and the echographic mode B and color Doppler. They have searched for some specific sign like " whirlpool sign " representing the winding of the mesenteric vein around the superior mesenteric arterywith color Doppler with arciform pattern of the midgut, hydro-meconium level in the dilated loops and position of mesenteric vessels for evaluation of the intestinal (mal) rotation. Gold standard was surgery or foetopathology if performed.

Study Type

Observational

Enrollment (Actual)

13

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Uhmontpellier

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

All pregnant women

Description

Inclusion Criteria:

  • postnatal diagnosis of prenatal volvulus based on post-natal findings and prenatal imaging findings

Exclusion Criteria:

  • the absence of prenatal imaging assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pregnant patients seen for second or third trimester
Foetus with diagnosis of prenatal volvulus based on post-natal findings and prenatal imaging findings
Fetal ultrasound during the second or third trimester Postnatal surgery Post mortem examination

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
echography
Time Frame: during the second (22-24 weeks) after ultrasound screening
Observation of specific signs using echography for the diagnosis of fetal during the second (22-24 weeks) and the third (31-34 weeks) trimester after ultrasound screening and when diagnostic ultrasound were performedmidgut volvulus
during the second (22-24 weeks) after ultrasound screening
echography
Time Frame: the third (31-34 weeks) trimester after ultrasound screening
Observation of specific signs using echography for the diagnosis of fetal
the third (31-34 weeks) trimester after ultrasound screening

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ultrasound signs of complication
Time Frame: the third (31-34 weeks) after ultrasound screening
Observation of ultrasound signs of complication of midgut volvulus during the pregnancy like meconial pseudocyst, ascites, meconial peritonitis.
the third (31-34 weeks) after ultrasound screening
ultrasound signs of complication
Time Frame: during the second (22-24 weeks) after ultrasound screening
Observation of ultrasound signs of complication of midgut volvulus during the pregnancy like meconial pseudocyst, ascites, meconial peritonitis.
during the second (22-24 weeks) after ultrasound screening
ultrasound signs of complication
Time Frame: 1 day
Observation of ultrasound signs of complication of midgut volvulus during the pregnancy like meconial pseudocyst, ascites, meconial peritonitis after diagnostic ultrasound.
1 day
ultrasound signs of complication
Time Frame: just after delivery
Observation of ultrasound signs of complication of midgut volvulus during the pregnancy like meconial pseudocyst, ascites, meconial peritonitis.
just after delivery
presence or not of the volvulus
Time Frame: 1 day
Observation of surgery outcome like presence or not of the volvulus after diagnostic ultrasound
1 day
presence or not of the volvulus
Time Frame: during the second (22-24 weeks) after ultrasound screening
Observation of surgery outcome like presence or not of the volvulus
during the second (22-24 weeks) after ultrasound screening
presence or not of the volvulus
Time Frame: just after delivery
Observation of surgery outcome like presence or not of the volvulus
just after delivery
presence or not of the volvulus
Time Frame: the third (31-34 weeks) after ultrasound screening
Observation of surgery outcome like presence or not of the volvulus
the third (31-34 weeks) after ultrasound screening
presence or not ileal atresia.
Time Frame: during the second (22-24 weeks) after ultrasound screening
Observation of surgery outcome like presence or not ileal atresia
during the second (22-24 weeks) after ultrasound screening
presence or not ileal atresia.
Time Frame: the third (31-34 weeks) after ultrasound screening
Observation of surgery outcome like presence or not ileal atresia
the third (31-34 weeks) after ultrasound screening
presence or not ileal atresia.
Time Frame: just after delivery
Observation of surgery outcome like presence or not ileal atresia
just after delivery
presence or not ileal atresia.
Time Frame: 1 day
Observation of surgery outcome like presence or not ileal atresia after diagnostic ultrasound
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2006

Primary Completion (ACTUAL)

July 1, 2017

Study Completion (ACTUAL)

September 30, 2017

Study Registration Dates

First Submitted

October 25, 2017

First Submitted That Met QC Criteria

December 4, 2017

First Posted (ACTUAL)

December 5, 2017

Study Record Updates

Last Update Posted (ACTUAL)

December 5, 2017

Last Update Submitted That Met QC Criteria

December 4, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fetal Volvulus

3
Subscribe